KESPRID

This brand name is authorized in Nigeria.

Active ingredients

The drug KESPRID contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII N3PA6559FT - ESOMEPRAZOLE
 

Esomeprazole is the S-isomer of omeprazole and reduces gastric acid secretion through a specific targeted mechanism of action. Esomeprazole is a weak base and is concentrated and converted to the active form in the highly acidic environment of the secretory canaliculi of the parietal cell, where it inhibits the enzyme H+ K+ -ATPase – the acid pump and inhibits both basal and stimulated acid secretion.

 
Read more about Esomeprazole
2
UNII 5587267Z69 - DOMPERIDONE
 

Domperidone is a dopamine antagonist with anti-emetic properties, Domperidone does not readily cross the blood-brain barrier. In domperidone users, especially in adults, extrapyramidal side effects are very rare, but domperidone promotes the release of prolactin from the pituitary.

 
Read more about Domperidone

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
B6-6203 Tablet Kesprid Tablet TAB 40 mg; 20 mg Film coated tablet Each tablet contains: Esomeprazole Magnesium 40 mg, Domperidone 20 mg 16/12/2021

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database B6-6203

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.